330729P

C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0)

Avanti Research^™ - A Croda Brand

• Synonym(e): D-glucosyl-β-1,1′-N-pentadecanoyl-D-erythro-sphingosine-d7
• Empirische Formel (Hill-System): C₃₉H₆₈D₇NO₈
• CAS-Nummer: 2315262-18-9
• Molekulargewicht: 693.06
• UNSPSC-Code: 12352211
• NACRES: NA.12

Eigenschaften

• Assay: 99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 1 mg (330729P-1MG)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O

Beschreibung

Allgemeine Beschreibung

C15 Glucosyl(β) Ceramide-d7 (d18:1-D7/15:0) is a deuterated derivative of C15 Glucosyl(β) Ceramide. β-Glucosyl ceramide (β-GlcCer) is an intracellular metabolite. It is the first intermediate in the synthesis of glycosphigolipids. β-GlcCer is an endogenous ligand of Mincle.

Biochem./physiol. Wirkung

β-Glucosyl ceramide (β-GlcCer) exhibits immunostimulatory activity. Accumulation of β-GlcCer is associated with Gaucher disease.

Verpackung

5 mL Amber Glass Screw Cap Vial

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable